Novel and promising approaches in COVID-19 treatment. (COVID-19 dedicated issue.)
Journal of Research in Pharmacy
; 25(6):772-784, 2021.
Article
in English
| GIM | ID: covidwho-1761604
ABSTRACT
Novel coronavirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe respiratory infectious disease, known as coronavirus disease-19 (COVID-19). Over the past few months, a considerable rise in the incidence rate and prevalence of COVID-19 infection have been witnessed. Considering the high disease burden and rapid spread of the COVID-19 and no effective treatment is currently existing, stem cells, engineered nanobiomaterials, natural killer cells based therapy, RNA metabolites and extracellular vesicles are promising alternatives to tackle devastating epidemic. This review spotlights the applications and potential of above-mentioned methods in the treatment of COVID-19.
63231-63-0; coronavirus disease 2019; disease incidence; disease prevalence; human diseases; nanomaterials; natural killer cells; pandemics; reviews; Rna; stem cell therapy; stem cells; therapy; viral diseases; immunotherapy; man; Severe acute respiratory syndrome coronavirus 2; Homo; Hominidae; primates; mammals; vertebrates; Chordata; animals; eukaryotes; Severe acute respiratory syndrome-related coronavirus; Betacoronavirus; Coronavirinae; Coronaviridae; Nidovirales; positive-sense ssRNA Viruses; ssRNA Viruses; RNA Viruses; viruses; ribonucleic acid; SARS-CoV-2; therapeutics; viral infections
Full text:
Available
Collection:
Databases of international organizations
Database:
GIM
Language:
English
Journal:
Journal of Research in Pharmacy
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS